All lobbying filings

THE MCMANUS GROUP

Lobbying for BIOWOUND SOLUTIONS · Biologics Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Nevada · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

HR 5768
Skin Substitute Access and Payment Reform Act
S 2561
Skin Substitute Access and Payment Reform Act of 2025
HR 6852
Advanced Wound Care and Regenerative Medicine Access and Reform Act

Lobbying activity 1

Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). H.R.6852 - To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program. Issues related to skin substitute payment in 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.